Streptococcus pneumoniae type 33f capsular polysaccharide antigen Completed Phase 2 Trials for Relapsing Forms of Multiple Sclerosis Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02097849Vaccination Response in Tecfidera-Treated Versus Interferon-Treated Participants With Relapsing Forms of Multiple Sclerosis.